BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1602618)

  • 1. [Essential thrombocythemia that transformed to myelofibrosis after three years].
    Akimoto Y; Ishiyama T; Sano M; Ueno H; Nakamaki T; Hino K; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1992 Apr; 33(4):520-4. PubMed ID: 1602618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis].
    Uesugi Y; Toba K; Nikkuni K; Fuse I; Koike T; Shibata A
    Rinsho Ketsueki; 1995 Oct; 36(10):1210-6. PubMed ID: 8531333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Essential thrombocythemia transformed to myelofibrosis with myeloid metaplasia after seven years].
    Yamagishi M; Yamamoto T; Ohmori M
    Rinsho Ketsueki; 1991 Mar; 32(3):239-43. PubMed ID: 2041165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R; Thiele J; Fischer R; Diehl V
    Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
    [No Abstract]   [Full Text] [Related]  

  • 7. [Essential thrombocythemia transformed to acute myeloblastic leukemia].
    Okuda M; Shishido T; Sato A; Nagai T; Sugawara T; Kameoka J; Kaneda K; Meguro K; Fukuhara O; Sakurai T
    Rinsho Ketsueki; 1990 Oct; 31(10):1689-93. PubMed ID: 2255058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic transformation of essential thrombocythemia. A case report.
    Honma K; Nemoto K; Ohnishi Y; Kimura K
    Acta Pathol Jpn; 1989 Oct; 39(10):670-6. PubMed ID: 2589080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neutrophilic myelofibrosis; a case report].
    Okamoto R; Harano H; Tamura T; Tanabe J; Fujita H; Fukawa H; Kanamori H; Matsuźaki M; Motomura S; Mohri H
    Rinsho Ketsueki; 1993 Aug; 34(8):957-61. PubMed ID: 8411651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary (essential) thrombocythemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocytosis--a critical evaluation of clinical and histomorphological data.
    Thiele J; Zankovich R; Steinberg T; Kremer B; Fischer R; Diehl V
    Acta Haematol; 1989; 81(4):192-202. PubMed ID: 2474228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
    Thiele J; Kvasnicka HM; Werden C; Zankovich R; Diehl V; Fischer R
    Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of post-essential thrombocythemia myelofibrosis with severe osteosclerosis].
    Lee KK; Cho HI; Chi HS; Kim DY; Chae SL; Huh HJ
    Korean J Lab Med; 2010 Apr; 30(2):122-5. PubMed ID: 20445328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL; Ortiz-Hidalgo C
    Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis.
    Geissler K; Jäger E; Gisslinger B; Thiele J; Schwarzinger I; Gisslinger H
    Am J Hematol; 2014 Dec; 89(12):1157-8. PubMed ID: 25112775
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrosis identified in the bone marrow biopsies of patients with essential thrombocythemia: its incidence and significance for the differential diagnostic considerations.
    Marcinek J; Plank L; Szépe P; Balhárek T
    Cesk Patol; 2008 Jul; 44(3):62-6. PubMed ID: 18783136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
    Katayama T; Masuoka H; Yoshida M; Watanabe R; Nishiwaki K; Shimada T; Kaito K; Ochiai S; Kobayashi M; Sakai O
    Rinsho Ketsueki; 1992 Apr; 33(4):488-93. PubMed ID: 1602613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary myelofibrosis transforming into multiple subcutaneous monoblastoma--a case report].
    Hamamoto K; Taniguchi H; Ohga S; Nagano T; Kishimoto Y; Kitajima H; Fujimoto M; Kimura T; Fujitake H; Yasunaga K
    Rinsho Ketsueki; 1991 Nov; 32(11):1481-5. PubMed ID: 1758057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of the active and latent forms of TGF-β1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis.
    Ponce CC; de Lourdes F Chauffaille M; Ihara SS; Silva MR
    Med Oncol; 2012 Dec; 29(4):2337-44. PubMed ID: 22200991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.